Marc Caragea, DO
Physical Medicine & Rehabilitation · Salt Lake City, UTNPI 1487158960
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,275 of the $4,785 with a category attached, or 68.4%. 22 manufacturers reported payments, led by Boston Scientific at 37.0% of the total. Reporting peaked in 2024 at $2,538 and has fallen 51.7% since, to $1,226 in 2025.
Across 75 payments — averaging $63.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$1K
- Nevro Corp.$598
- Stryker$350
- SPR Therapeutics, Inc$175
- Inari Medical, Inc.$94
- plus $595 from 16 others
What the payments were for
- Travel & lodging$1,51032%
- Food & beverage$3,27568%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $1,770 |
| Medtronic | 23 | $1,203 |
| Nevro Corp. | 9 | $598 |
| Stryker | 6 | $350 |
| SPR Therapeutics, Inc | 3 | $175 |
| Inari Medical, Inc. | 4 | $94 |
| Stratus Medical, LLC | 1 | $76 |
| Vertex | 3 | $73 |
| Globus Medical | 3 | $69 |
| Saluda Medical Americas, Inc. | 1 | $48 |
| Bioventus LLC | 2 | $46 |
| Peerless Surgical Inc. | 1 | $46 |
| Abbott | 1 | $43 |
| Avanos Medical | 2 | $34 |
| AbbVie | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Vericel Corporation | 1 | $21 |
| Nalu Medical, Inc. | 1 | $20 |
| Stimwave Technologies Incorporated | 1 | $19 |
| Curonix LLC | 1 | $19 |
| Amgen | 1 | $18 |
| Vertos Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$373
- INTELLIS ADAPTIVESTIM$373
- SPINEJACK$361
- KYPHON EXPRESS II KYPHOPAK TRAY$143
- INCEPTIV$113
- Accurian$106
- MULTIGEN 2$106
- GENERAL PAIN MANAGEMENT$104
How this compares
$4,785 in reported general payments places this provider in the 85th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 215 | $1,979 |
| Baclofen | 272 | $1,556 |
| Pregabalin | 11 | $323 |
| Meloxicam | 28 | $93 |
| Methylprednisolone | 13 | $91 |
| Diazepam | 52 | $37 |
| Tramadol Hcl | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Salt Lake City
- Timothy GrangeSalt Lake City$11K
- Steven EdgleySalt Lake City$8K
- Taylor BurnhamSalt Lake City$7K
- Nicholas GavernSalt Lake City$5K
- Arlan HenrieSalt Lake City$4K
- Max EpsteinSalt Lake City$4K
- Aaron CongerSalt Lake City$2K
- Gabriel Martinez AlvarezSalt Lake City$2K
- Jeffrey RosenbluthSalt Lake City$1K
- Derek KreteSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.